The Senolytic Drug Navitoclax (ABT-263) Causes Trabecular Bone Loss and Impaired Osteoprogenitor Function in Aged MiceAnuj K. Sharma, Meghan E. McGee‐Lawrence|Frontiers in Cell and Developmental Biology|2020Cited by 126